HIC2
Basic information
Region (hg38): 22:21417371-21451463
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HIC2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 55 | 56 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 56 | 2 | 1 |
Variants in HIC2
This is a list of pathogenic ClinVar variants found in the HIC2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-21442850-G-T | not specified | Uncertain significance (Jun 17, 2024) | ||
22-21444923-T-C | not specified | Uncertain significance (Feb 27, 2024) | ||
22-21444925-G-C | not specified | Uncertain significance (Jan 29, 2025) | ||
22-21444929-G-A | not specified | Uncertain significance (Jul 30, 2023) | ||
22-21444930-C-T | not specified | Uncertain significance (Jun 30, 2022) | ||
22-21444944-G-A | not specified | Uncertain significance (Aug 11, 2024) | ||
22-21444953-G-A | not specified | Uncertain significance (Nov 26, 2024) | ||
22-21444971-C-T | not specified | Uncertain significance (Feb 10, 2023) | ||
22-21445040-A-G | not specified | Uncertain significance (Feb 22, 2025) | ||
22-21445054-G-C | not specified | Uncertain significance (Dec 28, 2023) | ||
22-21445261-C-T | Likely benign (Feb 01, 2023) | |||
22-21445308-A-G | not specified | Uncertain significance (May 25, 2022) | ||
22-21445347-C-T | not specified | Likely benign (Mar 22, 2023) | ||
22-21445368-G-A | not specified | Uncertain significance (Jul 20, 2022) | ||
22-21445385-C-T | not specified | Uncertain significance (Jan 30, 2024) | ||
22-21445415-C-T | Likely benign (Mar 01, 2025) | |||
22-21445416-G-A | not specified | Uncertain significance (Feb 26, 2025) | ||
22-21445425-G-C | not specified | Uncertain significance (Jan 23, 2024) | ||
22-21445440-G-T | not specified | Uncertain significance (May 30, 2024) | ||
22-21445455-C-T | not specified | Uncertain significance (Oct 30, 2023) | ||
22-21445466-C-T | not specified | Uncertain significance (Dec 02, 2022) | ||
22-21445488-A-G | not specified | Uncertain significance (Nov 07, 2022) | ||
22-21445489-C-G | not specified | Uncertain significance (Aug 21, 2024) | ||
22-21445541-C-T | not specified | Uncertain significance (Nov 17, 2023) | ||
22-21445550-T-A | not specified | Uncertain significance (Feb 14, 2025) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HIC2 | protein_coding | protein_coding | ENST00000443632 | 2 | 34060 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.997 | 0.00332 | 123229 | 0 | 2 | 123231 | 0.00000811 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.05 | 282 | 397 | 0.710 | 0.0000268 | 3974 |
Missense in Polyphen | 32 | 80.536 | 0.39734 | 643 | ||
Synonymous | -2.34 | 217 | 177 | 1.22 | 0.0000133 | 1265 |
Loss of Function | 3.80 | 0 | 16.8 | 0.00 | 7.98e-7 | 193 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000903 | 0.00000903 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000329 | 0.0000329 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional repressor.;
Recessive Scores
- pRec
- 0.125
Intolerance Scores
- loftool
- 0.0150
- rvis_EVS
- -0.4
- rvis_percentile_EVS
- 26.85
Haploinsufficiency Scores
- pHI
- 0.660
- hipred
- Y
- hipred_score
- 0.768
- ghis
- 0.619
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.327
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hic2
- Phenotype
- muscle phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; embryo phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;negative regulation of transcription, DNA-templated
- Cellular component
- nucleus
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA binding;protein C-terminus binding;metal ion binding